Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Spondylitis, Ankylosing × Adalimumab × Clear all

Phase

Phase 4 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1 Sarcoidosis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1

Interventions

golimumab 1 Vaccines 1 Tumor Necrosis Factors 1 Sulfasalazine 1 Saline Solution 1 Meloxicam 1 Herpes Zoster Vaccine 1 Etoricoxib 1 Etanercept 1 Celecoxib 1 Anti-Inflammatory Agents, Non-Steroidal 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡